Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

APRI 2000 + : revenue, balance sheet and financial ratios

APRI 2000 + is a French company founded 11 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in COURNON-D'AUVERGNE (63800), this company of category PME shows in 2023 a net income positive of 26 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - APRI 2000 + (SIREN 808558480)
Indicator 2023
Revenue N/C
Net income 26 256 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2023, APRI 2000 + generates positive net income of 26 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

26 256 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 97%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

97.13%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

45.847%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

55.0%

Solvency indicators evolution
APRI 2000 +

Sector positioning

Debt ratio
97.13 2023
2023
Q1: 0.0
Med: 5.57
Q3: 50.77
Average

In 2023, the debt ratio of APRI 2000 + (97.13) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
45.85% 2023
2023
Q1: 13.47%
Med: 38.42%
Q3: 58.45%
Good

In 2023, the financial autonomy of APRI 2000 + (45.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 910.37. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

910.369

Liquidity indicators evolution
APRI 2000 +

Sector positioning

Liquidity ratio
910.37 2023
2023
Q1: 133.58
Med: 205.53
Q3: 329.15
Excellent

In 2023, the liquidity ratio of APRI 2000 + (910.37) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of APRI 2000 + in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of APRI 2000 + is estimated at 21 569 € (range 8 209€ - 78 769€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
124 transactions
8k€ 21k€ 78k€
21 569 € Range: 8 209€ - 78 769€
NAF 5 all-time

Valuation method used

Net Income Multiple
26 256 € × 0.8x = 21 570 €
Range: 8 210€ - 78 770€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare APRI 2000 + with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about APRI 2000 +

What is the revenue of APRI 2000 + ?

The revenue of APRI 2000 + is not publicly disclosed (confidential accounts filed with INPI).

Is APRI 2000 + profitable?

Yes, APRI 2000 + generated a net profit of 26 k€ in 2023.

Where is the headquarters of APRI 2000 + ?

The headquarters of APRI 2000 + is located in COURNON-D'AUVERGNE (63800), in the department Puy-de-Dome.

Where to find the tax return of APRI 2000 + ?

The tax return of APRI 2000 + is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does APRI 2000 + operate?

APRI 2000 + operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.